148 related articles for article (PubMed ID: 15606388)
21. HBsAg seropositive status and survival after renal transplantation: meta-analysis of observational studies.
Fabrizi F; Martin P; Dixit V; Kanwal F; Dulai G
Am J Transplant; 2005 Dec; 5(12):2913-21. PubMed ID: 16303005
[TBL] [Abstract][Full Text] [Related]
22. Differential Effect of Viral Hepatitis Infection on Mortality among Korean Maintenance Dialysis Patients: A Prospective Multicenter Cohort Study.
Kwon E; Cho JH; Jang HM; Kim YS; Kang SW; Yang CW; Kim NH; Kim HJ; Park JM; Lee JE; Jung HY; Choi JY; Park SH; Kim CD; Kim YL;
PLoS One; 2015; 10(8):e0135476. PubMed ID: 26263373
[TBL] [Abstract][Full Text] [Related]
23. Survival in patients treated by long-term dialysis compared with the general population.
Nordio M; Limido A; Maggiore U; Nichelatti M; Postorino M; Quintaliani G;
Am J Kidney Dis; 2012 Jun; 59(6):819-28. PubMed ID: 22361043
[TBL] [Abstract][Full Text] [Related]
24. Pegylated interferon monotherapy of chronic hepatitis C in dialysis patients: Meta-analysis of clinical trials.
Fabrizi F; Dixit V; Messa P; Martin P
J Med Virol; 2010 May; 82(5):768-75. PubMed ID: 20336712
[TBL] [Abstract][Full Text] [Related]
25. Hepatitis status and mortality in hemodialysis population.
Santoro D; Mazzaglia G; Savica V; Li Vecchi M; Bellinghieri G
Ren Fail; 2009; 31(1):6-12. PubMed ID: 19142803
[TBL] [Abstract][Full Text] [Related]
26. Hepatitis C treatment in patients with kidney disease.
Fabrizi F; Aghemo A; Messa P
Kidney Int; 2013 Nov; 84(5):874-9. PubMed ID: 23823603
[TBL] [Abstract][Full Text] [Related]
27. Hepatocellular carcinoma in uremic patients: is there evidence for an increased risk of mortality?
Lee YH; Hsu CY; Hsia CY; Huang YH; Su CW; Lin HC; Lee RC; Chiou YY; Huo TI
J Gastroenterol Hepatol; 2013 Feb; 28(2):348-56. PubMed ID: 23190248
[TBL] [Abstract][Full Text] [Related]
28. Meta-analysis: the adjuvant role of thymopentin on immunological response to hepatitis B virus vaccine in end-stage renal disease.
Fabrizi F; Dixit V; Martin P
Aliment Pharmacol Ther; 2006 Jun; 23(11):1559-66. PubMed ID: 16696803
[TBL] [Abstract][Full Text] [Related]
29. Safety and effectiveness of response-guided therapy using pegylated interferon and ribavirin for chronic hepatitis C virus infection in patients on maintenance dialysis.
Goel A; Bhadauria DS; Kaul A; Prasad N; Gupta A; Sharma RK; Rai P; Aggarwal R
Nephrology (Carlton); 2017 Sep; 22(9):706-711. PubMed ID: 27286895
[TBL] [Abstract][Full Text] [Related]
30. Long-term outcome of kidney transplantation in patients with hepatitis C virus infection.
Huo TI; Yang WC; Wu JC; King KL; Lin CY; Loong CC; Lui WY; Chang FY; Lee SD
Hepatogastroenterology; 2001; 48(37):169-73. PubMed ID: 11268958
[TBL] [Abstract][Full Text] [Related]
31. Antiviral therapy of hepatitis C in chronic kidney diseases: meta-analysis of controlled clinical trials.
Fabrizi F; Ganeshan SV; Lunghi G; Messa P; Martin P
J Viral Hepat; 2008 Aug; 15(8):600-6. PubMed ID: 18444984
[TBL] [Abstract][Full Text] [Related]
32. Effects of concomitant hepatitis C virus infection in patients with underlying lupus nephritis on long-term renal outcome.
Mitwalli AH; Hayat A; Alwakeel J; Hammad D
Nephrol Dial Transplant; 2012 Feb; 27(2):627-32. PubMed ID: 21771749
[TBL] [Abstract][Full Text] [Related]
33. 'Real-life' experience with direct-acting antiviral agents for hepatitis C virus in end-stage renal disease.
García-Agudo R; Aoufi-Rabih S; Salgueira-Lazo M; González-Corvillo C; Fabrizi F
Int J Artif Organs; 2018 Jul; 41(7):363-370. PubMed ID: 29582685
[TBL] [Abstract][Full Text] [Related]
34. [Natural history of HBV in dialysis population].
Fabrizi F; Martin P; Lunghi G; Ponticelli C
G Ital Nefrol; 2004; 21(1):21-8. PubMed ID: 15356843
[TBL] [Abstract][Full Text] [Related]
35. Mortality in hepatitis C-positive patients treated with peritoneal dialysis.
Wang SM; Liu JH; Chou CY; Huang CC; Shih CM; Chen W
Perit Dial Int; 2008; 28(2):183-7. PubMed ID: 18332455
[TBL] [Abstract][Full Text] [Related]
36. Hepatitis C virus infection and kidney transplantation: a review for clinicians.
Einollahi B; Alavian SM
Iran J Kidney Dis; 2010 Jan; 4(1):1-8. PubMed ID: 20081297
[TBL] [Abstract][Full Text] [Related]
37. Recent advances on hepatitis C virus in dialysis population.
Fabrizi F; Messa P; Martin P
Kidney Blood Press Res; 2014; 39(4):260-71. PubMed ID: 25171295
[TBL] [Abstract][Full Text] [Related]
38. Cardiovascular and noncardiovascular mortality among patients starting dialysis.
de Jager DJ; Grootendorst DC; Jager KJ; van Dijk PC; Tomas LM; Ansell D; Collart F; Finne P; Heaf JG; De Meester J; Wetzels JF; Rosendaal FR; Dekker FW
JAMA; 2009 Oct; 302(16):1782-9. PubMed ID: 19861670
[TBL] [Abstract][Full Text] [Related]
39. Meta-analysis: levamisole improves the immune response to hepatitis B vaccine in dialysis patients.
Fabrizi F; Dixit V; Messa P; Martin P
Aliment Pharmacol Ther; 2010 Sep; 32(6):756-62. PubMed ID: 20662784
[TBL] [Abstract][Full Text] [Related]
40. Prognosis of chronic hepatitis C: results of a large, prospective cohort study.
Niederau C; Lange S; Heintges T; Erhardt A; Buschkamp M; Hürter D; Nawrocki M; Kruska L; Hensel F; Petry W; Häussinger D
Hepatology; 1998 Dec; 28(6):1687-95. PubMed ID: 9828236
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
